Spyros Kintzios, Head of Corporate Development & Strategy of the Tsetis Pharmaceutical Group, receiving an award at the Prix Galien 2025.

April - LactoLevure® named Best Nutraceutical at the Prix Galien Awards 2025

Written by Georgia Venizelea on .

LactoLevure®, a research and development product of UNI-PHARMA, received the Prix Galien Award in the Nutraceuticals category, during the award ceremony held on April 24.

LactoLevure® is a breakthrough formulation that not only protects and restores the intestinal microbiota, but also sets itself apart from other probiotics on the market by innovating in two key areas:

It is the first probiotic blend launched in Greece, with strains that have been scientifically proven to support not only prevention but also the treatment of medical conditions, such as the eradication of Helicobacter pylori and the management of Irritable Bowel Syndrome (IBS).

It is the only probiotic in Greece included in official scientific guidelines, both national and international, for the management of specific medical conditions.